Core Viewpoint - The company is actively monitoring global infectious disease prevention and antiviral drug research needs, providing non-clinical research technical support to domestic and internationally positioned clients, with steady progress in various collaborative projects [1] Group 1: Company Operations - Non-clinical research and bioanalysis services are crucial components of the company's pharmaceutical service segment, which has maintained steady growth driven by the demand for innovative drug development [1] - The company aims to continuously strengthen its technical capabilities to promote the long-term stable development of its pharmaceutical service business [1]

证券日报网讯1月29日，华测检测（300012）在互动平台回答投资者提问时表示，苏州华测生物是公司 医药服务板块在非临床研究领域的重要平台，已通过国家药监局(NMPA)药物GLP认证并多次顺利复 审，同时获得AAALACInternational完全认证，具备开展病毒及抗病毒药物相关药效学、安全性评价、 毒代动力学及生物分析等研究的合规资质与技术能力。 ...

Core Viewpoint - The company is actively monitoring global public health dynamics, including the recent spread of new viruses, and has initiated relevant technical research and preparedness efforts [1] Group 1: Company Actions - The company's medical laboratory is developing and validating testing methods in response to the recent virus transmission [1] - The laboratory is also following the application process for relevant compliance qualifications [1] - The company emphasizes its commitment to public health safety and social responsibility [1] Group 2: Future Plans - The company will strictly adhere to regulatory requirements and market demands in advancing its initiatives [1] - Continuous communication with relevant departments will be maintained to prepare for technical responses to public health emergencies [1]

Group 1 - The company Guolai Detection held its 16th meeting of the second board on January 28, 2026, to discuss daily related transaction limits [1] - The meeting was conducted both in-person and via communication methods [1] Group 2 - The investigation into the "Jie Wo Rui" redemption crisis on the Shuibei Gold platform revealed a 40-fold leverage bet, indicating that the platform incurs losses as gold prices rise [1] - The platform's owner claims to still be in Shenzhen, while investors express dissatisfaction with the proposed redemption plan, which offers only 20% of the principal [1]

Core Viewpoint - The company is leading the development of five group standards, including the "Technical Requirements for Safety Systems of Humanoid Robots," and is actively working on their implementation in collaboration with industry leaders and automotive companies [1] Group 1: Standard Development and Implementation - The company is progressing in the implementation of the standards according to industry norms [1] - Collaboration with relevant industry enterprises and institutions is ongoing to ensure the standards meet the needs of industrial development [1] Group 2: Impact on Business and Industry - The implementation of these standards is expected to enhance the company's technological leadership in the relevant fields [1] - The standards will contribute to strengthening the company's competitiveness in the testing business and its influence within the industry [1] - The specific impacts will gradually become evident as the industry develops [1]

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 华测检测回复：尊敬的投资者您好，公司高度重视医药检测与新药研发服务的国际化能力建设。目前， 公司医药相关实验室已建立符合NMPA、FDA等主要监管机构技术要求的质量管理体系，部分实验室已 完成FDA注册并接受现场检查，可为客户提供支持中美欧等多区域申报的检测与研究服务。依托药学 CMC研究、非临床研究、生物分析及注册申报等一体化服务能力，公司已为多项创新药项目提供中美 双报及国际申报支持。鉴于信息披露及商业保密原则，公司不对具体项目数量及客户情况作单独披露。 从行业特征看，具备国际合规能力的检测与研究服务对技术、质量体系及人才要求较高，具备一定的服 务溢价能力，具体毛利水平同时也受项目类型、服务内容及客户结构等多因素影响。未来，公司将持续 完善国际法规对接能力，稳步提升创新药国际化检测服务的市场竞争力，谢谢。 证券之星消息，华测检测(300012)01月29日在投资者关系平台上答复投资者关心的问题。 投资者提问：创新药出海已成趋势，公司医疗器械实验室是国内首家获FDA-ASCA认可的第 ...

Core Viewpoint - The company does not directly provide medical testing services but offers calibration and testing services through its subsidiaries [1] Group 1: Company Services - The subsidiary Suzhou Saibao provides calibration services for medical-related equipment, serving numerous medical device manufacturers and pharmaceutical companies [1] - The subsidiary Shenzhen Zhongrentong Testing offers EMC testing services for gene sequencers, measuring devices, and in vitro diagnostic equipment [1]

（记者 王晓波） 每经AI快讯，有投资者在投资者互动平台提问：贵司的无人机EL红外入网质量测试可以介绍一下这方 面的业务吗？ 联检科技（301115.SZ）1月29日在投资者互动平台表示，公司的无人机EL/红外测试可为光伏电站的光 伏组件提供EL电致发光性能测试、红外扫描成像等服务。入网质量测试可在光伏电站并网后为其提供 输出交流电的电能质量、逆变器效率、光伏组串交流/直流线损等测试服务。 ...

一、董事会会议召开情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002967 证券简称：广电计量公告编号：2026-003 广电计量检测集团股份有限公司 第五届董事会第二十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 广电计量检测集团股份有限公司（以下简称"公司"）第五届董事会第二十八次会议于2026年1月28日以 通讯方式召开。会议通知于2026年1月23日以书面及电子邮件、电话等方式发出。会议应出席董事9名， 实际出席董事9名，符合《公司法》等有关法律法规和公司章程的规定，合法有效。 二、董事会会议审议情况 审议通过《关于向特定对象发行股票募集资金专项账户的议案》 同意公司向特定对象发行股票募集资金专项账户，并于募集资金到账后适时与保荐机构、存放募集资金 的商业银行签订监管协议。 表决结果：同意9票，反对0票，弃权0票。 三、备查文件 经与会董事签字并加盖董事会印章的第五届董事会第二十八次会议决议。 特此公告。 广电计量检测集团股份有限公司董事会 2026年1月29日 ...

Core Viewpoint - Anke Detection (300572.SZ) expects a loss of 200 million to 100 million yuan in 2025, with a non-recurring loss of 248.36 million to 148.36 million yuan due to reduced demand for vehicle inspections caused by policy changes [1] Company Summary - The company has been significantly impacted by two overlapping vehicle inspection policies, leading to a substantial decrease in inspection demand as most vehicles are under ten years old and only require inspection once within that period [1] - The actual performance of the company's vehicle inspection station operations has not met expectations, resulting in a significant discrepancy between actual and expected results [1] - The company has made preliminary assessments to impair goodwill and related assets from acquired vehicle inspection stations due to the adverse financial outlook [1] Industry Summary - In 2024, new policies aimed at transforming and upgrading the automotive consumption market in China are expected to accelerate the elimination of old vehicles, further squeezing the vehicle inspection business and contributing to a downward trend in overall inspection frequency demand [1] - The Ministry of Ecology and Environment and other departments are set to issue opinions to enhance the regulation of vehicle emissions inspection institutions, which may increase market demand for vehicle inspection systems and help restore the company's profitability [1]